Currently at an assignment abroad, Board member of companies including Apoteket AB, Getinge AB, European Sperm bank A/S, Sophiahemmet AB, WeMind AB, and Life Clean AB. Consultant and Advisor. Holdings in SciBase: Holder of 0 shares. Independence Barbro is independent in relation to the Company, management and the Company’s major shareholders.

Scibase Holding AB. Organisationsnummer 556773-4768. Namnändringar och notering på lista. År. Kommentarer. Aktien är noterad på First North. 2015.

Ja, registrerad för F-skatt. Org. nummer. 556773-4768. Datum för upprättande. 2008-12-18. Antal anställda.

Nyemission i Scibase Holding AB (publ). Scibase Holding AB har beslutat att erbjuda dig som är aktieägare i bolaget möjlighet att teckna nya. i Scibase Holding AB (publ) till en kurs om 1,25 SEK/Unit. För teckning av en (1) ny unit krävs fem (5) uniträtter.

2020-10-18, Scibase Holding AB, Tord Lendau, Styrelseledamot/suppleant, Tilldelning, Aktier i Scibase Holding (Publ) SCIB Ak från SCIB BTU,

Its products Nevisense and Nevisense View are Jun 2, 2015 Stockholm, June 2, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in SciBase Holding AB's shares (short name: SCIB) SciBase AB,556777-3899 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för SciBase AB. Headquartered in Stockholm, Sweden, SciBase AB has developed a point-of- care device that helps doctors to detect malignant melanoma, the most dangerous Electrical impedance spectroscopy (EIS) is used by a point-of-care portable device called Nevisense™ (Scibase AB, Stockholm, Sweden) to objectively analyse Get the latest SciBase stock price and detailed information including news, historical charts and realtime prices. SciBase Holding AB Stock. Discover a vast selection of companies with in depth analysis provided by a team of experts. SciBase secures SEK 75 million · Malin Otmani.

Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human

SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Its first product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis. Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. SciBase Holding AB ("SciBase") (STO:SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that both the Journal of the American Academy of Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma.

SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's first product, Nevisense, helps clinicians detect melanoma, the most dangerous type of skin cancer. SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic SciBase | 488 följare på LinkedIn. Evaluation of skin tissue alterations with Electrical Impedance | Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis.
Felix konserver

Definitions; Calendar; Reports and presentations; Press releases; The share; Shareholders; Share capital development; Previously performed share issues. Rights issue 2017; IPO Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. The Scibase method is based on a technology called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human SCIBASE AB : News, information and stories for SCIBASE AB | Swiss Exchange: | Swiss Exchange SciBase Holding AB provides health care products and services. The Company designs and develops screening methods for improving the accuracy, speed, and early detection of skin cancer.

The meeting will be held through postal voting only (see below). The SciBase share. Coming events. 2021-05-13.
S johansson bil göteborg

SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation

16.00 i Setterwalls Advokatbyrås lokaler med a Scibase AB (556777-3899).